Vanguard Group’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1M | Sell |
1,915,606
-24,617
| -1% | -$39.9K | ﹤0.01% | 3376 |
|
|
2025
Q1 | $1.39M | Sell |
1,940,223
-2,598
| -0.1% | -$1.87K | ﹤0.01% | 3606 |
|
|
2024
Q4 | $2.16M | Sell |
1,942,821
-11,464
| -0.6% | -$12.7K | ﹤0.01% | 3544 |
|
|
2024
Q3 | $1.37M | Hold |
1,954,285
| – | – | ﹤0.01% | 3675 |
|
|
2024
Q2 | $1.95M | Buy |
1,954,285
+141,386
| +8% | +$141K | ﹤0.01% | 3558 |
|
|
2024
Q1 | $4.3M | Buy |
1,812,899
+69,436
| +4% | +$165K | ﹤0.01% | 3354 |
|
|
2023
Q4 | $3.92M | Buy |
1,743,463
+27,017
| +2% | +$60.8K | ﹤0.01% | 3379 |
|
|
2023
Q3 | $3.64M | Buy |
1,716,446
+3,965
| +0.2% | +$8.41K | ﹤0.01% | 3378 |
|
|
2023
Q2 | $5.29M | Buy |
1,712,481
+133,183
| +8% | +$412K | ﹤0.01% | 3268 |
|
|
2023
Q1 | $8.5M | Buy |
1,579,298
+387,968
| +33% | +$2.09M | ﹤0.01% | 3022 |
|
|
2022
Q4 | $7.92M | Buy |
1,191,330
+534,188
| +81% | +$3.55M | ﹤0.01% | 3059 |
|
|
2022
Q3 | $2.62M | Hold |
657,142
| – | – | ﹤0.01% | 3633 |
|
|
2022
Q2 | $3.27M | Sell |
657,142
-3,305
| -0.5% | -$16.4K | ﹤0.01% | 3584 |
|
|
2022
Q1 | $3.99M | Sell |
660,447
-291,679
| -31% | -$1.76M | ﹤0.01% | 3636 |
|
|
2021
Q4 | $11.1M | Sell |
952,126
-348,930
| -27% | -$4.05M | ﹤0.01% | 3152 |
|
|
2021
Q3 | $20.4M | Buy |
1,301,056
+457,673
| +54% | +$7.18M | ﹤0.01% | 2855 |
|
|
2021
Q2 | $15.7M | Buy |
843,383
+36,821
| +5% | +$687K | ﹤0.01% | 2960 |
|
|
2021
Q1 | $34.8M | Buy |
+806,562
| New | +$34.8M | ﹤0.01% | 2503 |
|